Incidence of nocturnal hypoglycaemia in patients with Type 2 diabetes is comparable when either morning or bedtime insulin glargine is coadministered with glimepiride.

被引：0

作者：

Standl, E

Maxeiner, S

Schweitzer, MA

机构：

[1] Stadt Krankenhaus, Diabet Res Inst, Munich, Germany

[2] Diabet Practice, Bad Kreuznach, Germany

[3] Aventis Pharma Deutschland GmbH, Frankfurt, Germany

来源：

DIABETOLOGIA | 2003年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A6 / A6

页数：1

共 50 条

[1] Morning versus bedtime insulin glargine in combination with glimepiride: No difference in incidence of nocturnal hypoglycemia in patients with type 2 diabetes
Standl, E
Maxeiner, S
Schweitzer, MA
[J]. DIABETES, 2003, 52 : A134 - A134
[2] Glimepiride combined with morning insulin glargine, bedtime neutral protamine Hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes -: A randomized, controlled trial
Fritsche, A
Schweitzer, MA
Häring, HU
[J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (12) : 952 - 959
[3] Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: An assessment of treatment flexibility
Standl, E.
Maxeiner, S.
Raptis, S.
[J]. HORMONE AND METABOLIC RESEARCH, 2006, 38 (03) : 172 - 177
[4] Improved glycaemic control and reduced nocturnal hypoglycaemia in patients with Type 2 diabetes with morning administration of insulin glargine compared with NPH insulin
Fritsche, A
Schweitzer, MA
Häring, H
[J]. DIABETOLOGIA, 2002, 45 : A52 - A52
[5] Glycaemic control and hypoglycaemia in Asian Type 2 diabetes patients treated with insulin glargine plus glimepiride versus NPH insulin plus glimepiride
Pan, CY
Bianchi-Biscay, M
Chung, KD
Kim, KW
[J]. DIABETOLOGIA, 2004, 47 : A271 - A271
[6] Nocturnal glucose metabolism after a single bedtime injection of insulin glargine or NPH insulin in patients with type 2 diabetes
Fischer, Britta
Soydan, Nedim
Eckhard, Michael
Ehl, Julia
Kunz, Clemenis
Bretzel, Reinhard G.
Linn, Thomas
[J]. DIABETES, 2006, 55 : A111 - A111
[7] Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine Hagedorn insulin in patients with type 2 diabetes
Linn, Thomas
Fischer, Britta
Soydan, Nedim
Eckhard, Michael
Ehl, Julia
Kunz, Clemens
Bretzel, Reinhard G.
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10): : 3839 - 3846
[8] Efficacy and safety of a fixed dose combination of glimepiride and metformin versus glimepiride when added in to insulin glargine in patients with type 2 diabetes
Lee, J. -M.
Lee, J. -H.
Park, S. -H.
Kim, S. -J.
Park, K. -Y.
Lim, D. -M.
Chun, S. -W.
Lee, J. -M.
Park, K. -S.
[J]. DIABETOLOGIA, 2011, 54 : S422 - S422
[9] Lower incidence of nocturnal hypoglycaemia in patients with Type 2 diabetes treated with insulin glargine compared with NPH insulin, given as a combination regimen with oral agents.
Benedetti, MM
Hamburg, E
Dressler, A
Ziemen, M
[J]. DIABETOLOGIA, 2002, 45 : A259 - A259
[10] Reduced nocturnal hypoglycaemia with insulin degludec vs insulin glargine: a two year trial in Type 2 diabetes
Cariou, B.
Rodbard, H.
Zinman, B.
Philis-Tsimikas, A.
Handlesman, Y.
Skoth, T. V.
Chu, P-L
Mathieu, C.
[J]. DIABETIC MEDICINE, 2013, 30 : 55 - 55

← 1 2 3 4 5 →